ELYXYB Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Elyxyb, and what generic alternatives are available?
Elyxyb is a drug marketed by Bdsi and is included in one NDA. There are six patents protecting this drug.
This drug has twenty-four patent family members in twelve countries.
The generic ingredient in ELYXYB is celecoxib. There are twenty-six drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the celecoxib profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Elyxyb
A generic version of ELYXYB was approved as celecoxib by MYLAN on May 30th, 2014.
Summary for ELYXYB
International Patents: | 24 |
US Patents: | 6 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in ELYXYB? | ELYXYB excipients list |
DailyMed Link: | ELYXYB at DailyMed |

Anatomical Therapeutic Chemical (ATC) Classes for ELYXYB
US Patents and Regulatory Information for ELYXYB
ELYXYB is protected by six US patents and one FDA Regulatory Exclusivity.
Patents protecting ELYXYB
Oral composition of celecoxib for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS
Oral composition of celecoxib for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS
Oral composition of celecoxib for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS
Oral composition of celecoxib for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS
Oral composition of celecoxib for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS
Oral composition of celecoxib for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS
FDA Regulatory Exclusivity protecting ELYXYB
NEW PRODUCT
Exclusivity Expiration: See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bdsi | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Bdsi | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Bdsi | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Bdsi | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Bdsi | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Bdsi | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Bdsi | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ELYXYB
See the table below for patents covering ELYXYB around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | 112018074486 | composição oral de celecoxib para tratamento da dor | See Plans and Pricing |
China | 109496151 | 用于治疗疼痛的塞来昔布口服组合物 (ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN) | See Plans and Pricing |
European Patent Office | 3302429 | See Plans and Pricing | |
China | 107847437 | See Plans and Pricing | |
South Korea | 101994129 | See Plans and Pricing | |
New Zealand | 737561 | Oral composition of celecoxib for treatment of pain | See Plans and Pricing |
Russian Federation | 2708254 | Пероральная композиция целекоксиба для лечения боли (ORAL CELECOXIB COMPOSITION FOR TREATING PAIN) | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ELYXYB
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0731795 | 10075033 | Germany | See Plans and Pricing | PRODUCT NAME: CELECOXIB; NAT. REGISTRATION NO/DATE: 48802.00.00 20000518; FIRST REGISTRATION: SE 14838 19991203 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |